fig3

S-nitrosoglutathione reductase (GSNOR) deficiency accelerates cardiomyocyte differentiation of induced pluripotent stem cells

Figure 3. GSNOR loss of function alters S-nitrosylation and expression of GSK3β. (A) qRT-PCR analysis of Gsk3β in murine iPSCWT (white circles) and iPSCGSNOR-/- (black circles) during cardiomyocyte differentiation. (B) S-nitrosylation of Gsk3β in murine iPSCGSNOR-/- and iPSCWT as assessed by SNO-RAC on Day 4. Effects on Gsk3β mRNA levels, in (C) murine iPSCWT, following 3 h incubation with 3 different concentrations of the NO donor, GSNO, on Day 4, and in (D) hiPSCs (brown circles), following 24 h of incubation with GSNO beginning on Day 1. (E) Western blot analysis of Axin 1 and Hsp90 (internal control) in murine iPSCWT (white circles) and iPSCGSNOR-/- (black circles) on Day 0, 2, 4 and 6 of cardiomyocyte differentiation. qRT-PCR analysis of Axin 1 (F) and Axin 2 (G) in murine iPSCWT (white circles) and iPSCGSNOR-/- (black circles) during cardiomyocyte differentiation. Data are the mean ± SEM of 3 independent experiments. P-values were calculated using Student’s t-test at each time point. *P < 0.05.

The Journal of Cardiovascular Aging

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/